PMGC Holdings Inc. (ELAB) stock
ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/3095% below fair value
$1.48−0.18 (-10.84%)
Close on Nov 17, 2026Market cap $1.32MP/E –Yield –
PMGC gross margin
Gross margin is gross profit as a percentage of revenue.
PMGC's gross margin for the twelve months ending Sep 30, 2026 was 27.5%. For fiscal 2025 it was 31.4%, against 66.2% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 31.4% | −34.8 |
| FY2023 | Dec 31, 2023 | 66.2% | +7.9 |
| FY2022 | Dec 31, 2022 | 58.4% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 23.8% | −3.5 |
| Q2 FY2026 | Jun 30, 2026 | 29.5% | −45.2 |
| Q1 FY2026 | Mar 31, 2026 | 33.8% | −38.7 |
| Q4 FY2025 | Dec 31, 2025 | 35.3% | −37.2 |
| Q3 FY2025 | Sep 30, 2025 | 27.3% | −38.8 |
| Q3 FY2024 | Sep 30, 2024 | 74.7% | +8.7 |
| Q2 FY2024 | Jun 30, 2024 | 72.5% | +6.7 |
| Q1 FY2024 | Mar 31, 2024 | 72.5% | +3.6 |
| Q4 FY2023 | Dec 31, 2023 | 66.1% | +11.1 |
| Q3 FY2023 | Sep 30, 2023 | 66.0% | – |
| Q2 FY2023 | Jun 30, 2023 | 65.8% | – |
| Q1 FY2023 | Mar 31, 2023 | 68.9% | – |
| Q3 FY2022 | Sep 30, 2022 | 55.0% | – |
See a number that looks wrong?